Mandy Lehmann

Mandy Lehmann, Ph.D. has a diverse and extensive work experience spanning multiple industries and roles. Mandy is currently serving as the Vice President of Biopharma Business Development Europe at Caris Life Sciences since August 2021. Prior to this, from November 2018 to July 2021, they worked as the Director of Business Development - Translational Oncology Solutions at Champions Oncology, Inc.

Mandy has also worked at Illumina, where they held two positions. Firstly, as a Senior Sales Representative from August 2016 to November 2018, they excelled in evaluating genomic projects and providing solutions for next-generation sequencing, array products, IVD, and services to customers in research, clinical, and biotech sectors. Mandy achieved outstanding results and was recognized for exceeding quotas and achieving the highest account growth in their region. Secondly, from September 2011 to August 2016, they served as a Senior Technical Applications Scientist.

Before joining Illumina, Mandy worked at The Scripps Research Institute as a Research Associate from April 2008 to September 2011. Mandy also interned at the Office of Technology Development at the institute from September 2010 to June 2011. Prior to that, they served as a Research Assistant at the Max Delbrueck Center from April 2001 to September 2003 while simultaneously working as a Research Assistant at the University of California, San Diego in an unspecified timeframe in 2002 and 2003.

Mandy Lehmann, Ph.D. obtained their education from multiple prestigious institutions. Mandy pursued their Diplom/Master degree in Human Biology from The Philipp University of Marburg, graduating in the years 1997 to 2002. Subsequently, they pursued a Ph.D. in Pharmaceutical Biology from both Ludwig-Maximilians-Universität München and Scripps Research. This program took place from 2003 to 2008.